Review Support for Scientific and Regulatory Complexity

Combine pharma-experienced reviewers with AI-assisted analysis for matters involving lab notebooks, technical records, regulatory language, spreadsheets, and large document populations.

Human expertise remains central

aiR can help prioritize and analyze content, while reviewers apply industry context and escalate scientific, privilege, and matter-specific questions.